Zoetis (NYSE:ZTS) Sees Large Volume Increase – Here’s What Happened

by · The Cerbat Gem

Zoetis Inc. (NYSE:ZTS – Get Free Report) shares saw an uptick in trading volume on Tuesday . 10,007,063 shares were traded during trading, an increase of 198% from the previous session’s volume of 3,353,767 shares.The stock last traded at $123.6830 and had previously closed at $120.98.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. UBS Group reduced their price target on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Morgan Stanley reduced their target price on Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a report on Monday, November 10th. Stifel Nicolaus lowered their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a report on Tuesday, November 18th. Argus reaffirmed a “buy” rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Bank of America cut Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a research note on Monday. Six equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $161.55.

View Our Latest Research Report on Zoetis

Zoetis Stock Up 2.5%

The firm’s 50 day simple moving average is $130.46 and its 200-day simple moving average is $145.62. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. The stock has a market capitalization of $54.64 billion, a price-to-earnings ratio of 20.87, a price-to-earnings-growth ratio of 2.46 and a beta of 0.97.

Zoetis (NYSE:ZTS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter last year, the company earned $1.58 EPS. Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. Zoetis’s dividend payout ratio is presently 35.69%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ZTS. Scott & Selber Inc. raised its position in Zoetis by 0.6% in the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock valued at $1,817,000 after purchasing an additional 67 shares during the last quarter. North Star Asset Management Inc. increased its stake in shares of Zoetis by 4.9% in the second quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after buying an additional 67 shares during the period. Secure Asset Management LLC raised its holdings in Zoetis by 2.9% in the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock valued at $382,000 after buying an additional 68 shares during the last quarter. Moment Partners LLC raised its holdings in Zoetis by 3.2% in the 2nd quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock valued at $367,000 after buying an additional 72 shares during the last quarter. Finally, Bank of Nova Scotia Trust Co. boosted its position in Zoetis by 4.6% during the 2nd quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock worth $264,000 after buying an additional 74 shares during the period. Institutional investors own 92.80% of the company’s stock.

About Zoetis

(Get Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Featured Stories